Literature DB >> 11191718

The association of low serum cholesterol with depression and suicidal behaviours: new hypotheses for the missing link.

R Manfredini1, S Caracciolo, R Salmi, B Boari, A Tomelli, M Gallerani.   

Abstract

Several observational studies indicate that reduction of serum cholesterol levels is related to an increase in violent deaths and suicide but the nature of this possible relationship remains unclear. Many confounding factors, e.g. poor health, depression and loss of appetite may play a role in the apparent relationship between serum cholesterol levels and suicide. Two separate phenomena should be considered: lowering total cholesterol and low total cholesterol. This review considers the evidence from epidemiological studies on serum cholesterol lowering and psychiatric disturbances. The available evidence does not seem to substantiate the view that large-scale intervention to reduce cholesterol concentrations could lead to more violent and aggressive behaviour, and generally greater unhappiness. In recent trials using statin treatment, there were slightly fewer deaths from accidents and suicide in the treated group compared with the placebo group. We believe that clinicians should not be deterred from prescribing cholesterol-lowering drugs, to reduce the risk of death from coronary heart disease, when they are indicated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191718     DOI: 10.1177/147323000002800601

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  10 in total

1.  Major depressive disorder and cardiometabolic disease risk among sub-Saharan African adults.

Authors:  Bizu Gelaye; Michelle A Williams; Seblewengel Lemma; Yemane Berhane; Jesse R Fann; Ann Vander Stoep; Xiao-Hua Andrew Zhou
Journal:  Diabetes Metab Syndr       Date:  2014-06-14

2.  The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.

Authors:  Jeff C Huffman; Christopher M Celano; James L Januzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

3.  Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels.

Authors:  Angelo M Scanu; Janet Hinman
Journal:  Lipids       Date:  2002-05       Impact factor: 1.880

Review 4.  Assessing the role of drugs in suicidal ideation and suicidality.

Authors:  David M Reith; Liza Edmonds
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 5.  Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies.

Authors:  Shunquan Wu; Yingying Ding; Fuquan Wu; Guoming Xie; Jun Hou; Panyong Mao
Journal:  J Psychiatry Neurosci       Date:  2016-01       Impact factor: 6.186

Review 6.  Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid-lowering agents.

Authors:  Michael Tatley; Ruth Savage
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

7.  A controlled study of serum lipid profiles in Indian patients with depressive episode.

Authors:  Bichitra Nanda Patra; Sudhir K Khandelwal; Rakesh K Chadda; Lakshmy Ramakrishnan
Journal:  Indian J Psychol Med       Date:  2014-04

8.  Improvement of Glycemic Control in Insulin-Dependent Diabetics with Depression by Concomitant Treatment with Antidepressants.

Authors:  Jana Radojkovic; Natasa Sikanic; Zoran Bukumiric; Marijana Tadic; Nada Kostic; Rade Babic
Journal:  Med Sci Monit       Date:  2016-06-22

9.  Persistently high psychological well-being predicts better HDL cholesterol and triglyceride levels: findings from the midlife in the U.S. (MIDUS) longitudinal study.

Authors:  Barry T Radler; Attilio Rigotti; Carol D Ryff
Journal:  Lipids Health Dis       Date:  2018-01-03       Impact factor: 3.876

10.  Association between lipid ratio and depression: a cross-sectional study.

Authors:  A Lum Han
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.